F-18 FDG PET detection of a medullary thyroid carcinoma in a patient with metastatic colonic cancer; literature review

Annales d'Endocrinologie

Volumn 70, Issue 6, 2009, Pages 468-472

  Cohen, R ^a   Bihan, H ^a   des Guetz, G ^a   Wind, P ^a   Martin, A ^a  

^a AVICENNE HOSPITAL   (France)

Author keywords

Calcitonin; Colon cancer; FDG PET; Medullary thyroid carcinoma

Indexed keywords

CALCITONIN; CARCINOEMBRYONIC ANTIGEN; FLUORODEOXYGLUCOSE F 18;

AGED; ARTICLE; ASPIRATION BIOPSY; CALCITONIN BLOOD LEVEL; CANCER RECURRENCE; CASE REPORT; COLON CANCER; COLON OBSTRUCTION; DIAGNOSTIC IMAGING; ECHOGRAPHY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; METASTASIS; ONCOGENE RET; POSITRON EMISSION TOMOGRAPHY; SIGMOID; SIGMOIDECTOMY; THYROID INCIDENTALOMA; THYROID MEDULLARY CARCINOMA; THYROID NODULE;

AGED; BIOPSY, FINE-NEEDLE; CALCITONIN; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, MEDULLARY; COLONIC NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; THYROID NEOPLASMS; THYROIDECTOMY; ULTRASONOGRAPHY;

EID: 71149116575     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2009.06.033     Document Type: Article

References (25)

1. Kebebew E., Tresler P.A., Siperstein A.E., Duh Q.Y., and Clark O.H. Normal thyroid pathology in patients undergoing thyroidectomy for finding a RET gene germline mutation: a report of three cases and review of the literature. Thyroid 9 (1999) 127-131
2. Modigliani E., Cohen R., Campos J.M., Conte-Devolx B., Maes B., Boneu A., et al. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. Clin Endocrinol 48 (1998) 265-273
3. Leboulleux S., Baudin E., Travagli J.P., and Schlumberger M. Medullary thyroid carcinoma. Clin Endocrinol (Oxf) 61 (2004) 299-310
4. Scollo C., Baudin E., Travagli J.P., Caillou B., Bellon N., Leboulleux S., et al. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. J Clin Endocrinol Metab 88 (2003) 2070-2075
5. AACE/AME Task Force on Thyroid Nodules: American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocrine Practice 2006; 12:63-102.
6. Nam S.Y., Roh J.L., Kim J.S., Lee J.H., Choi S.H., and Kim S.Y. Focal uptake of (18) F-fluorodeoxyglucose by thyroid in patients with non thyroidal head and neck cancers. Clin Endocrinol (Oxf) 67 (2007) 135-139
7. Cohen M.S., Arslan N., Dehdashti F., Doherty G.M., Lairmore T.C., Brunt L.M., et al. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery 130 (2001) 941-946
8. Van den Bruel A., Maes A., De Potter T., Mortelmans L., Drijkoningen M., Van Damme B., et al. Clinical relevance of thyroid fluorodeoxyglucose-whole-body positron emission tomography incidentaloma. J Clin Endocrinol Metab 87 (2002) 1517-1520
9. Kang K.W., Kim S.K., Kang H.S., Lee E.S., Sim J.S., Lee I.G., et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose-positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metab 88 (2003) 4100-4104
10. Kim T.Y., Kim W.B., Ryu J.S., Gong G., Hong S.J., and Shong Y.K. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope 115 (2005) 1074-1078
11. Yi J.G., Marom E.M., Munden R.F., Truong M.T., Macapinlac H.A., Gladish G.W., et al. Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer. Radiology 236 (2005) 271-275
12. Choi J.Y., Lee K.S., Kim H.J., Shim Y.M., Kwon O.J., Park K., et al. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization. J Nuclear Med 47 (2006) 609-615
13. Are C., Hsu J.F., Schoder H., Shah J.P., Larson S.M., and Shaha A.R. FDG PET detected thyroid incidentalomas: need for further investigation?. Ann Surg Oncol 14 (2007) 239-247
14. Bogsrud T.V., Karantanis D., Nathan M.A., Mullan B.P., Wiseman G.A., Collins D.A., et al. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT. Nucl Med Commun 28 (2007) 373-381
15. Chen Y.K., Ding H.J., Chen K.T., Chen Y.L., Liao A.C., Shen Y.Y., et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose-positron emission tomography for cancer screening in healthy subjects. Anticancer Res 25 (2005) 1421-1426
16. Chu Q.D., Connor M.S., Lilien D.L., Johnson L.W., Turnage R.H., and Li B.D. Positron emission tomography (PET) positive thyroid incidentaloma: the risk of malignancy observed in a tertiary referral center. Am Surg 72 (2006) 272-275
17. Rougier P., Calmettes C., Laplanche A., Travagli J.P., Lefevre M., Parmentier C., et al. The values of calcitonin and carcinoembryonic antigen in the treatment and management of non-familial medullary thyroid carcinoma. Cancer 51 (1983) 855-862
18. Kwak J.Y., Kim E.K., Yun M., Cho A., Kim M.J., Son E.J., et al. Thyroid incidentalomas identified by 18F-FDG PET: sonographic correlation. Am J Roentgenol 191 (2008) 598-603
19. Noordzij M.J., de Heide L.J., Links T.P., Jager P.L., and Wolfenbuttel B.H. Four patients with incidentalomas of the thyroid discovered on 18 fluorodeoxyglucose-positron emission tomography (FDG PET). Ned Tijdschr Geneeskd 151 (2007) 2337-2341
20. Lièvre A., Leboulleux S., Boige V., Travagli J.P., Dromain C., Elias D., et al. Thyroid metastases from colorectal cancer: The institute Gustave Roussy experience. Eur J Cancer 42 (2006) 1756-1759
21. Iguchi T., Matsuoka J., Sato S., Okumura Y., Omori M., Mifune H., et al. F-18 FDG PET demonstration of a thyroid metastasis in a patient with colon cancer. Clin Nucl Med 32 (2007) 361-362
22. Giraudet A.L., Vanel D., Leboulleux S., Auperin A., Dromain C., Chami L., et al. Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels. J Clin Endocrinol Metab 92 (2007) 4185-4189
23. Oudoux A., Salaun P.Y., Bournaud C., Campion L., Ansquer C., Rousseau C., et al. Sensitivity and prognostic value of positron emission tomography with F-18 fluorodeoxyglucose and sensitivity of immunoscintigraphy in patients with medullary thyroid carcinoma treated with anticarcinoembryonic antigen-targeted radioimmunotherapy. J Clin Endocrinol Metab 92 (2007) 4590-4597
24. Giardiello F.M., Offerhaus G.J., Lee D.H., Krush A.J., Tersmette A.C., Booker S.V., et al. Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut 34 (1993) 1394-1396
25. Martinez M., Virally M.L., Guillausseau-Scholer C., Vincenot M., Samuel-Lajeunesse J., Mauvais-Jarvis F., et al. High carcinoembryonic antigen level following cancer surgery: another way to detect thyroid medullary carcinoma. Rev Med Interne 21 (2000) 897-900